Detalhe da pesquisa
1.
In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS.
J Immunother
; 45(2): 104-118, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864807
2.
Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial.
Haematologica
; 96(7): 972-9, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21459795
3.
Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
Thromb Res
; 116(3): 233-40, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15935832
4.
Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis.
J Clin Oncol
; 32(4): 288-96, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24366930
5.
A Phase 3, Randomized, Placebo-controlled Trial of Filgrastim in Patients with Haematological Malignancies Undergoing Matched-related Allogeneic Bone Marrow Transplantation.
Arch Drug Inf
; 1(3): 89-96, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19639030